Stride director awarded 4,097 restricted shares in Form 4
Stride, Inc. reported an equity grant to one of its directors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Stride, Inc. reported an equity grant to one of its directors. On December 4, 2025, the director acquired 4,097 shares of Stride common stock at a price of $0, reflecting a restricted stock award rather than an open-market purchase. Following this transaction, the director beneficially owns 42,201 shares, held directly.
The new shares are restricted and will vest on the earlier of December 4, 2026 or the date of the next annual meeting of Stride, Inc. stockholders. This filing is a routine Form 4 disclosure of director equity compensation and does not describe any broader corporate events or financial results.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,097 | $0.00 | $0.00 |
Footnotes (1)
- F1. These shares are restricted and will vest on the earlier of (a) December 4, 2026, or (b) the next annual meeting of the stockholders of Stride, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Stride, Inc. (LRN) disclose in this Form 4?
What is the reporting person’s relationship to Stride, Inc. (LRN)?
Is this Stride, Inc. (LRN) Form 4 filed by one person or a group?
AI-generated analysis. How Rhea-AI works. Not financial advice.